Recruiting PHASE4 INTERVENTIONAL 2-arm NCT06284642

Early Lumbar Drainage Combined With Intrathecal Urokinase Injection for Treatment of Severe Aneurysmal SAH (LD-ITUK)

Effectiveness and Safety of Early Lumbar Drainage Combined With Intrathecal Urokinase Injection in the Treatment of Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK): a Multicentral Randomized Control Trial

Sponsor: Changhai Hospital

Conditions Aneurysmal Subarachnoid Hemorrhage

Interventions Placebo Urokinase

Updated 4 times since 2024 Last updated: Apr 10, 2024 Started: Mar 28, 2024 Primary completion: Jan 30, 2026 Completion: Jun 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06284642, this PHASE4 trial focuses on Aneurysmal Subarachnoid Hemorrhage and remains actively recruiting participants. Sponsored by Changhai Hospital, it has been updated 4 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
May 2024 — Jul 2024 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Mar 2024 — May 2024 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Changhai Hospital
Second Affiliated Hospital of Nanchang University

Data source: Second Affiliated Hospital of Nanchang University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nanchang, China